BioCentury | Jan 19, 2009
Regulation

Barnyard to bedside

...Evaluation & Research (CBER), told reporters after the meeting. If approved, ATryn would compete with Thrombate III...
...The life-threatening nature of the condition ruled out a placebo-controlled study, and uncertain supplies of Thrombate III...
...approved because of supply shortages of Thrombate III. Epstein said FDA has received anecdotal reports of Thrombate III...
BioCentury | Sep 16, 1996
Company News

Cardiovascular Diagnostics, Bayer Corp. deal

...AT), a naturally occurring anticoagulant protein. Under the agreement, CVDI can access Bayer's trial of Thrombate III...
...submission. Bayer has the right of first refusal to co-promote the product in conjunction with Thrombate III...
Items per page:
1 - 2 of 2